• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据溃疡性结肠炎活动情况对生物标志物进行最佳定位。

Optimal positioning of biomarkers according to ulcerative colitis activity.

作者信息

Ishida Natsuki, Takebe Tomohiro, Takahashi Kenichi, Asai Yusuke, Matsuura Tomoharu, Yamade Mihoko, Iwaizumi Moriya, Hamaya Yasushi, Yamada Takanori, Osawa Satoshi, Sugimoto Ken

机构信息

First Department of Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, Shizuoka, 431-3192, Japan.

Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

出版信息

Sci Rep. 2025 Jun 6;15(1):19916. doi: 10.1038/s41598-025-04908-2.

DOI:10.1038/s41598-025-04908-2
PMID:40481096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12144207/
Abstract

The diagnostic performance and clinical utility of fecal calprotectin (FC), fecal immunochemical occult blood test (FIT), leucine-rich alpha-2 glycoprotein (LRG), C-reactive protein (CRP), and prostaglandin E-major urinary metabolite (PGE-MUM) as established biomarkers for ulcerative colitis (UC) were evaluated. Significant correlations were observed between the clinical activity index, Mayo endoscopic subscore (MES), and each biomarker. Among MES groups, fecal biomarkers demonstrated significant differences, except between MES 2 and MES 3. CRP and LRG showed significant differences, except between MES 1 and MES 2. PGE-MUM exhibited significant differences across all MES groups. Areas under the curve (AUCs) for receiver operating characteristic (ROC) analysis in predicting MES 0 or 1 were as follows: FC, 0.891; FIT, 0.853; LRG, 0.723; CRP, 0.747; PGE-MUM, 0.795. For predicting MES 0 alone, AUCs were as follows: FC, 0.885; FIT, 0.845; LRG, 0.708; CRP, 0.691; PGE-MUM, 0.732. In distinguishing between each MES group, fecal biomarkers exhibited the highest AUC and accuracy in differentiating MES 0 from MES 1, whereas LRG, CRP, and PGE-MUM were most effective in differentiating MES 2 from MES 3. In summary, in UC, fecal biomarkers effectively detect mucosal healing, whereas LRG, CRP, and PGE-MUM are valuable for assessing mucosal healing and active inflammation.

摘要

评估了粪便钙卫蛋白(FC)、粪便免疫化学潜血试验(FIT)、富含亮氨酸的α-2糖蛋白(LRG)、C反应蛋白(CRP)和前列腺素E主要尿代谢物(PGE-MUM)作为溃疡性结肠炎(UC)既定生物标志物的诊断性能和临床效用。观察到临床活动指数、梅奥内镜亚评分(MES)与每种生物标志物之间存在显著相关性。在MES组中,除MES 2和MES 3之间外,粪便生物标志物显示出显著差异。CRP和LRG显示出显著差异,除MES 1和MES 2之间外。PGE-MUM在所有MES组中均表现出显著差异。预测MES 0或1时,受试者工作特征(ROC)分析的曲线下面积(AUC)如下:FC为0.891;FIT为0.853;LRG为0.723;CRP为0.747;PGE-MUM为0.795。仅预测MES 0时,AUC如下:FC为0.885;FIT为0.845;LRG为0.708;CRP为0.691;PGE-MUM为0.732。在区分每个MES组时,粪便生物标志物在区分MES 0和MES 1方面表现出最高的AUC和准确性,而LRG、CRP和PGE-MUM在区分MES 2和MES 3方面最有效。总之,在UC中,粪便生物标志物可有效检测黏膜愈合,而LRG、CRP和PGE-MUM在评估黏膜愈合和活动性炎症方面具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e4d/12144207/11a54957bb05/41598_2025_4908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e4d/12144207/3679a51262f2/41598_2025_4908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e4d/12144207/3bc8216efeff/41598_2025_4908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e4d/12144207/11a54957bb05/41598_2025_4908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e4d/12144207/3679a51262f2/41598_2025_4908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e4d/12144207/3bc8216efeff/41598_2025_4908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e4d/12144207/11a54957bb05/41598_2025_4908_Fig3_HTML.jpg

相似文献

1
Optimal positioning of biomarkers according to ulcerative colitis activity.根据溃疡性结肠炎活动情况对生物标志物进行最佳定位。
Sci Rep. 2025 Jun 6;15(1):19916. doi: 10.1038/s41598-025-04908-2.
2
Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center.粪便钙卫蛋白检测作为溃疡性结肠炎梅奥内镜亚评分生物标志物的诊断性能:来自三级转诊中心的结果
Inflamm Bowel Dis. 2024 Dec 5;30(12):2347-2355. doi: 10.1093/ibd/izae005.
3
Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.粪便钙卫蛋白比粪便免疫化学试验更能准确预测缓解期溃疡性结肠炎的黏膜愈合:一项前瞻性多中心研究。
Scand J Gastroenterol. 2020 Feb;55(2):163-168. doi: 10.1080/00365521.2020.1714716. Epub 2020 Jan 26.
4
C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.C-反应蛋白优于粪便生物标志物,用于评估溃疡性结肠炎的全结肠活跃性炎症。
Sci Rep. 2021 Jun 14;11(1):12431. doi: 10.1038/s41598-021-90558-z.
5
Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker.溃疡性结肠炎病程对免疫化学粪便隐血试验结果作为疾病活动生物标志物的有用性的影响。
Int J Colorectal Dis. 2020 Sep;35(9):1729-1739. doi: 10.1007/s00384-020-03636-5. Epub 2020 May 29.
6
Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.富含亮氨酸的α-2 糖蛋白是评估炎症性肠病临床和内镜疾病活动的可靠血清生物标志物。
Inflamm Bowel Dis. 2023 Sep 1;29(9):1399-1408. doi: 10.1093/ibd/izac230.
7
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.粪便钙卫蛋白可预测溃疡性结肠炎患者的黏膜完全愈合,且与溃疡性结肠炎内镜严重程度指数的相关性优于与梅奥内镜亚评分的相关性。
BMC Gastroenterol. 2017 Oct 23;17(1):110. doi: 10.1186/s12876-017-0669-7.
8
Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease.尿前列腺素代谢产物评估在炎症性肠病活动监测中的应用
Sci Rep. 2025 Jan 16;15(1):2135. doi: 10.1038/s41598-024-78154-3.
9
Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase.前列腺素 E-主要尿代谢物诊断溃疡性结肠炎缓解期患者的黏膜愈合。
J Gastroenterol Hepatol. 2022 May;37(5):847-854. doi: 10.1111/jgh.15782. Epub 2022 Feb 14.
10
Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.通过粪便钙卫蛋白与粪便免疫化学检测评估溃疡性结肠炎的黏膜愈合情况
Am J Gastroenterol. 2015 Jun;110(6):873-80. doi: 10.1038/ajg.2015.66. Epub 2015 Mar 31.

本文引用的文献

1
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations.定义综合疾病控制作为临床实践中溃疡性结肠炎的治疗目标:国际德尔菲共识推荐
J Crohns Colitis. 2024 Jan 27;18(1):91-105. doi: 10.1093/ecco-jcc/jjad130.
2
Utility of a rapid assay for prostaglandin E-major urinary metabolite as a biomarker in pediatric ulcerative colitis.快速检测前列腺素 E-主要尿代谢产物作为儿童溃疡性结肠炎生物标志物的效用。
Sci Rep. 2023 Jun 19;13(1):9898. doi: 10.1038/s41598-023-37145-6.
3
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.
美国胃肠病学会关于生物标志物在溃疡性结肠炎管理中作用的临床实践指南。
Gastroenterology. 2023 Mar;164(3):344-372. doi: 10.1053/j.gastro.2022.12.007.
4
Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.富含亮氨酸的α-2 糖蛋白是评估炎症性肠病临床和内镜疾病活动的可靠血清生物标志物。
Inflamm Bowel Dis. 2023 Sep 1;29(9):1399-1408. doi: 10.1093/ibd/izac230.
5
Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase.前列腺素 E-主要尿代谢物诊断溃疡性结肠炎缓解期患者的黏膜愈合。
J Gastroenterol Hepatol. 2022 May;37(5):847-854. doi: 10.1111/jgh.15782. Epub 2022 Feb 14.
6
C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.C-反应蛋白优于粪便生物标志物,用于评估溃疡性结肠炎的全结肠活跃性炎症。
Sci Rep. 2021 Jun 14;11(1):12431. doi: 10.1038/s41598-021-90558-z.
7
Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease.富含亮氨酸的α-2 糖蛋白作为炎症性肠病黏膜愈合的标志物。
Sci Rep. 2021 May 27;11(1):11086. doi: 10.1038/s41598-021-90441-x.
8
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.STRIDE-II:炎症性肠病(STRIDE)国际研究组织(IOIBD)治疗靶点选择更新:确定炎症性肠病靶向治疗策略的治疗目标。
Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19.
9
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.前列腺素 E-主要尿代谢物与粪便免疫化学隐血试验作为溃疡性结肠炎患者的生物标志物。
BMC Gastroenterol. 2020 Apr 19;20(1):114. doi: 10.1186/s12876-020-01256-5.
10
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.乌司奴单抗诱导和维持溃疡性结肠炎的治疗。
N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750.